Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. AHCO
stocks logo

AHCO

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
832.51M
-2.82%
0.340
-19.04%
798.18M
+2.61%
0.036
+50.71%
842.36M
+5.25%
0.187
+162.56%
Estimates Revision
The market is revising Upward the revenue expectations for AdaptHealth Corp. (AHCO) for FY2025, with the revenue forecasts being adjusted by 0.16% over the past three months. During the same period, the stock price has changed by -1.37%.
Revenue Estimates for FY2025
Revise Upward
up Image
+0.16%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-11.81%
In Past 3 Month
Stock Price
Go Down
down Image
-1.37%
In Past 3 Month
Wall Street analysts forecast AHCO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AHCO is 13.67 USD with a low forecast of 13.00 USD and a high forecast of 15.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Analyst Rating
Wall Street analysts forecast AHCO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AHCO is 13.67 USD with a low forecast of 13.00 USD and a high forecast of 15.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
0 Hold
0 Sell
Strong Buy
Current: 9.380
sliders
Low
13.00
Averages
13.67
High
15.00
Current: 9.380
sliders
Low
13.00
Averages
13.67
High
15.00
Canaccord
upgrade
$14 -> $15
2025-11-06
Reason
Canaccord
Price Target
$14 -> $15
2025-11-06
upgrade
Reason
Canaccord raised the firm's price target on AdaptHealth to $15 from $14. The firm raised its target and estimates to reflect updated 2026 estimates. They believe that there is the opportunity for multiple expansion as CEO Suzanne Foster's initiative to standardize the company's field operating model and organization structure to improve patient service and financial performance takes hold.
Truist
Buy
downgrade
$14 -> $13
2025-05-12
Reason
Truist
Price Target
$14 -> $13
2025-05-12
downgrade
Buy
Reason
Truist lowered the firm's price target on AdaptHealth to $13 from $14 and keeps a Buy rating on the shares as part of a broader research note on Health Care Services. The firm is updating its models to reflect Q1 results and updated guidance on select names, the analyst tells investors in a research note.
Baird
Eric Coldwell
Buy
Maintains
$14 → $16
2025-02-27
Reason
Baird
Eric Coldwell
Price Target
$14 → $16
2025-02-27
Maintains
Buy
Reason
Baird raised the firm's price target on AdaptHealth to $16 from $14 and keeps an Outperform rating on the shares. The firm said they posted good Q4 results and a positive 2025 outlook.
Truist Securities
David Macdonald
Strong Buy
Maintains
$12 → $14
2025-02-26
Reason
Truist Securities
David Macdonald
Price Target
$12 → $14
2025-02-26
Maintains
Strong Buy
Reason
RBC Capital
Ben Hendrix
Buy
Maintains
$11 → $14
2025-02-26
Reason
RBC Capital
Ben Hendrix
Price Target
$11 → $14
2025-02-26
Maintains
Buy
Reason
RBC Capital raised the firm's price target on AdaptHealth to $14 from $11 and keeps an Outperform rating on the shares after its Q4 earnings beat. The company saw a strong finish to 2024 and gave solid initial guidance, the analyst tells investors in a research note. Early signs that the strategic overhaul to the Diabetes business announced last quarter may be taking hold, the firm adds.
Canaccord Genuity
Richard Close
Strong Buy
Maintains
$13 → $14
2025-02-26
Reason
Canaccord Genuity
Richard Close
Price Target
$13 → $14
2025-02-26
Maintains
Strong Buy
Reason
Canaccord analyst Richard Close raised the firm's price target on AdaptHealth to $14 from $13 and keeps a Buy rating on the shares. The firm said 4Q was a step forward in rebuilding investor confidence for Adapt as results showed revenue upside and 2025 guidance that has revenue and adj-EBITDA ranges bracketing both Canaccord and consensus prior estimates, and a respectable FCF range of $180-$220 million.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Adapthealth Corp (AHCO.O) is 10.92, compared to its 5-year average forward P/E of 14.57. For a more detailed relative valuation and DCF analysis to assess Adapthealth Corp 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PE
14.57
Current PE
10.92
Overvalued PE
20.43
Undervalued PE
8.72

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
6.18
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
7.52
Undervalued EV/EBITDA
4.85

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.70
Current PS
0.00
Overvalued PS
1.08
Undervalued PS
0.32
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds areBuying! The buying amount has increased 1321.21% over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
AI Stock Picker
AI Stock Picker

AHCO News & Events

Events Timeline

(ET)
2025-11-04
07:48:37
AdaptHealth supports FY25 revenue forecast of $3.18B-$3.26B, in line with consensus of $3.23B.
select
2025-11-04
07:47:15
AdaptHealth announces Q3 earnings per share of 16 cents, below consensus estimate of 24 cents.
select
2025-08-05 (ET)
2025-08-05
09:30:52
AdaptHealth partners with national healthcare system for home medical equipment
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
8.0
12-04NASDAQ.COM
Significant Wednesday Options Trading: NLOP, MSM, AHCO

  • MSC Industrial Direct Options Activity: MSC Industrial Direct Co Inc (MSM) has seen a significant options volume of 15,048 contracts today, equating to 1.5 million underlying shares, which is 235.9% of its average daily trading volume.

  • High Volume Put Option for MSM: The $80 strike put option expiring on January 16, 2026, has particularly high activity, with 5,042 contracts traded, representing about 504,200 underlying shares.

  • AdaptHealth Corp Options Activity: AdaptHealth Corp (AHCO) has recorded an options volume of 12,117 contracts today, amounting to 1.2 million underlying shares, or 104.9% of its average daily trading volume.

  • High Volume Call Option for AHCO: The $10 strike call option expiring on January 16, 2026, is notably active, with 6,065 contracts traded, representing approximately 606,500 underlying shares.

[object Object]
Preview
1.0
11-26Newsfilter
AdaptHealth to Participate in BofA Securities Leveraged Finance Conference, Showcasing Healthcare Services
  • Conference Participation: AdaptHealth will participate in the BofA Securities Leveraged Finance Conference on December 2, 2025, in Boca Raton, FL, featuring a fireside chat at 8:10 a.m. ET, highlighting its leadership in healthcare services.
  • Business Overview: The company focuses on patient-centered healthcare-at-home solutions across four segments: Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home, reaching approximately 4.2 million patients annually across all 50 states.
  • Network Advantage: AdaptHealth operates around 630 locations and leverages a diversified referral network, including acute care hospitals and sleep labs, ensuring efficient delivery of medical equipment and related services to patients.
  • Market Positioning: By servicing beneficiaries of Medicare, Medicaid, and commercial insurance, the company addresses complex medical needs, further solidifying its competitive edge in the home healthcare market.
[object Object]
Preview
2.0
11-26NASDAQ.COM
Biotech and Healthcare Stocks Top After-Hours Gainers: ICU, CGTX, MESO, VRCA, AHCO

  • Biotech Gains in After-Hours Trading: Several small- and mid-cap biotech and healthcare companies saw significant gains in after-hours trading, driven by corporate updates and financing developments.

  • SeaStar Medical's Leadership Change: SeaStar Medical's stock rose nearly 10% after the appointment of Michael Messinger as Chief Financial Officer, boosting investor confidence despite no new news.

  • Cognition Therapeutics' Speculative Buying: Cognition Therapeutics rebounded almost 11% in after-hours trading, likely due to speculative buying interest, following a decline during regular trading hours.

  • Mesoblast's Revenue Projection: Mesoblast's shares increased after management projected over $30 million in gross revenue for the December quarter, indicating strong demand for its cell therapy product, Ryoncil.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Adapthealth Corp (AHCO) stock price today?

The current price of AHCO is 9.38 USD — it has increased 0.43 % in the last trading day.

arrow icon

What is Adapthealth Corp (AHCO)'s business?

AdaptHealth Corp. is a provider of patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company provides a full suite of medical products and solutions designed to help patients manage chronic conditions in the home. Its product and service offerings include sleep therapy equipment, supplies, and related services (including CPAP and bi PAP services) to individuals suffering from obstructive sleep apnea; medical devices and supplies to patients for the treatment of diabetes, including continuous glucose monitors and insulin pumps; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs. It operates in 50 states through its network of over 670 locations in 47 states.

arrow icon

What is the price predicton of AHCO Stock?

Wall Street analysts forecast AHCO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AHCO is 13.67 USD with a low forecast of 13.00 USD and a high forecast of 15.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Adapthealth Corp (AHCO)'s revenue for the last quarter?

Adapthealth Corp revenue for the last quarter amounts to 820.31M USD, increased 1.79 % YoY.

arrow icon

What is Adapthealth Corp (AHCO)'s earnings per share (EPS) for the last quarter?

Adapthealth Corp. EPS for the last quarter amounts to 0.16 USD, increased 6.67 % YoY.

arrow icon

What changes have occurred in the market's expectations for Adapthealth Corp (AHCO)'s fundamentals?

The market is revising Upward the revenue expectations for AdaptHealth Corp. (AHCO) for FY2025, with the revenue forecasts being adjusted by 0.16% over the past three months. During the same period, the stock price has changed by -1.37%.
arrow icon

How many employees does Adapthealth Corp (AHCO). have?

Adapthealth Corp (AHCO) has 10500 emplpoyees as of December 05 2025.

arrow icon

What is Adapthealth Corp (AHCO) market cap?

Today AHCO has the market capitalization of 1.27B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free